Study to Evaluate the Safety, Tolerability, and Efficacy of OTX-CSI in Subjects With Dry Eye Disease.
Clinical trial NCT04362670 · COMPLETED
Trial details
- NCT number
- NCT04362670
- Sponsor
- Ocular Therapeutix, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-23
- Primary completion
- 2021-08-11
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.